Medibio working with DuVal & Associates on Updated Regulatory Strategy

Medibio Announces Regulatory and Commercialisation Strategy Update Melbourne, Australia and Minneapolis, MN – 30 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company provides the following update on regulatory strategy. Effective 29 April, [...]